This paper provides the latest available data on women incarcerated for drug offences in Latin America, highlights the key human rights challenges they face in the criminal justice system, and offers policy recommendations.
This advocacy note outlines key issues for consideration as member states reflect on what has been achieved since 2009, and the implications for the next phase of the international drug policy regime.
In this response, IDPC analyses the 2017 INCB Annual Report, paying special attention to its foreword, its thematic chapter on treatment, as well as the cross-cutting issues of health, human rights and cannabis policies.
The 3rd Brandenburg Forum report outlines the discussions held by 56 experts from 15 countries on the state and direction of the global drug control regime in view of the 2019 CND Ministerial Segment.
This policy paper outlines the barriers for the integration of harm reduction into rehabilitation services in Indonesia and proposes policy recommendations to surpass them.
The IDPC network outlines four key asks for member states towards ensuring that future drug policies are firmly situated within the UN priorities of protecting health and human rights, promoting development and advancing peace and security.
IDPC members and allies contributed a number of submissions to the call for contributions of the OHCHR concerning the upcoming report on UNGASS implementation and human rights.
IDPC provides an overview of the intersections between human rights and drug control as enshrined in the UNGASS Outcome document, offering recommendations for a better coordination of these two spheres of international cooperation.
This paper seeks to contribute to understanding of existing policies related to harm reduction in Cambodia, as well as the challenges to and opportunities for improvement in order to reduce the health and socio-economic harms associated with drug use.
This Paper provides an analysis of critical public health problems for the Philippine prison population, in relation to HIV/AIDS and hepatitis C (HCV), and offers recommendations
for addressing these ‘twin epidemics.’
IDPC and MUCD provide an overview of the key models of regulation and offer general recommendations to improve public policies in areas where legislation is already in place and to improve decision-making in countries where reform is pending.
This paper provides recommendations for overcoming challenges in light of current policies and practices in Thailand so that the drug treatment system can result in improved health and human rights outcomes for people who use drugs and people dependant on drugs.
This year’s report, which includes content like interactive maps and data sets, is one of the agency’s most thorough and accessible publications to date.
IDPC and WACD summarise and review existing drug legislation from the 15 ECOWAS member states, as well as Mauritania and Morocco, concluding on the need for reform to align domestic laws with regional and international commitments.
In this advocacy note, IDPC offers some analysis and key recommendations on CBD and tramadol to inform the ECDD’s meeting set to take place in November 2017.
.pdf)
